FI751537A - - Google Patents

Info

Publication number
FI751537A
FI751537A FI751537A FI751537A FI751537A FI 751537 A FI751537 A FI 751537A FI 751537 A FI751537 A FI 751537A FI 751537 A FI751537 A FI 751537A FI 751537 A FI751537 A FI 751537A
Authority
FI
Finland
Application number
FI751537A
Other languages
Finnish (fi)
Other versions
FI61897B (fi
FI61897C (fi
Inventor
Erzsebet Mago
Jozsef Borsi
Endre Csanyi
Katalin Pik
Lajos Wolf
Original Assignee
Richter Gedeon Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyeszet filed Critical Richter Gedeon Vegyeszet
Publication of FI751537A publication Critical patent/FI751537A/fi
Publication of FI61897B publication Critical patent/FI61897B/fi
Application granted granted Critical
Publication of FI61897C publication Critical patent/FI61897C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/04—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 8
    • C07D457/06—Lysergic acid amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/02—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with hydrocarbon or substituted hydrocarbon radicals, attached in position 8

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FI751537A 1974-05-28 1975-05-27 Foerfarande foer framstaellning av nya terapeutiskt anvaendbara n-(1-(acyloximetyl)-4-(omega-nitroguanidino)-butyl)-dihydrolysergamider samt syraadditionssalter daerav FI61897C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HUGO1272A HU169073B (nl) 1974-05-28 1974-05-28
HUGO001272 1974-05-28

Publications (3)

Publication Number Publication Date
FI751537A true FI751537A (nl) 1975-11-29
FI61897B FI61897B (fi) 1982-06-30
FI61897C FI61897C (fi) 1982-10-11

Family

ID=10996767

Family Applications (1)

Application Number Title Priority Date Filing Date
FI751537A FI61897C (fi) 1974-05-28 1975-05-27 Foerfarande foer framstaellning av nya terapeutiskt anvaendbara n-(1-(acyloximetyl)-4-(omega-nitroguanidino)-butyl)-dihydrolysergamider samt syraadditionssalter daerav

Country Status (21)

Country Link
US (1) US4005089A (nl)
JP (1) JPS5218718B2 (nl)
AT (1) AT346501B (nl)
BE (1) BE829518A (nl)
BG (1) BG27374A3 (nl)
CA (1) CA1051878A (nl)
CS (1) CS194227B2 (nl)
DD (1) DD121639A5 (nl)
DE (1) DE2523743A1 (nl)
DK (1) DK143801C (nl)
ES (1) ES437994A1 (nl)
FI (1) FI61897C (nl)
FR (1) FR2272671B1 (nl)
GB (1) GB1474337A (nl)
HU (1) HU169073B (nl)
IL (1) IL47361A (nl)
NL (1) NL7506276A (nl)
PL (1) PL98944B1 (nl)
SE (1) SE419548B (nl)
SU (1) SU625612A3 (nl)
YU (1) YU135575A (nl)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4064249A (en) * 1974-05-28 1977-12-20 Richter Gedeon Vegyeszeti Gyar Rt. Compounds with ergoline skeleton
HU172649B (hu) * 1975-04-24 1978-11-28 Gyogyszerkutato Intezet Sposob poluchenija novykh biologicheski aktivnykh lizergamidov
HU172479B (hu) * 1976-03-09 1978-09-28 Gyogyszerkutato Intezet Sposob poluchenija novykh soedinenij s ehrgolenovymi i
JPS577172Y2 (nl) * 1977-03-17 1982-02-10
JPS582957U (ja) * 1981-06-30 1983-01-10 松下電子工業株式会社 高圧ナトリウムランプ
IT1171432B (it) * 1981-08-03 1987-06-10 Fidia Farmaceutici Amidi organiche derivate da lipidi azotati utilizzabili come farmaci
US4675322A (en) * 1984-12-10 1987-06-23 Eli Lilly And Company 1-Substituted-6-n-propyl-8β-methylthio-methylergolines
DD238051A1 (de) * 1985-06-10 1986-08-06 Dresden Arzneimittel Verfahren zur herstellung neuer lysergsaeureamide
EP2515654A4 (en) * 2009-12-23 2013-04-24 Map Pharmaceuticals Inc NEW ERGOLINANALOGA
MX2013015373A (es) 2011-06-23 2014-02-11 Map Pharmaceuticals Inc Nuevos analogos de fluoroergolina.
SG11201403434YA (en) 2011-12-19 2014-09-26 Map Pharmaceuticals Inc Novel iso-ergoline derivatives
SG10201506202RA (en) 2011-12-21 2015-09-29 Map Pharmaceuticals Inc Novel neuromodulatory compounds
US9012640B2 (en) 2012-06-22 2015-04-21 Map Pharmaceuticals, Inc. Cabergoline derivatives
BR112017015487A2 (pt) * 2015-01-20 2018-01-30 Xoc Pharmaceuticals Inc Composto; composição; método de tratamento e/ou prevenção de enxaqueca, als, doença de alzheimer, doença de parkinson, distúrbios extrapirimidais, depressão, náusea, êmese, síndrome das pernas inquietas, insônia, agressão, doença de huntington, doença cardiopulmonar, fibrogênese, hipertensão arterial pulmonar, ansiedade, dependências a drogas, distonia, parassonia ou hiperlactinemia em um indivíduo; métodos de agonização dos receptores d2, 5-ht1d, 5-ht1a e 5-ht2c, em um indivíduo; método de antagonização do receptor d3 em um indivíduo; métodos de agonização seletiva dos receptores 5 -ht1d, e 5-ht2c, método de fornecimento de atividade de antagonista funcional no receptor 5 -ht2b ou no receptor 5-ht7, ou em ambos, em um indivíduo; método de fornecimento de atividade de antagonista funcional nos receptores adrenérgicos em um indivíduo
WO2018223065A1 (en) 2017-06-01 2018-12-06 Xoc Pharmaceuticals, Inc. Ergoline derivatives for use in medicine

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2533699A (en) * 1950-12-12 Amines containing the king system
US2673850A (en) * 1951-07-28 1954-03-30 Sandoz Ag Piperazides of the lysergic acid series
US2946796A (en) * 1958-10-15 1960-07-26 Grace W R & Co Salts of ergot alkaloids
CH475252A (de) * 1966-02-08 1969-07-15 Sandoz Ag Verfahren zur Herstellung neuer Lysergsäure-Derivate
SE396753B (sv) * 1970-05-18 1977-10-03 Richter Gedeon Vegyeszet Analogiforfarande for framstellning av en forening tillhorande dihydrolysergsyraserien
US3901893A (en) * 1970-05-18 1975-08-26 Richter Gedeon Vegyeszet New dihydro-lysergic acid derivative
IL41409A (en) * 1972-02-04 1977-04-29 Richter Gedeon Vegyeszet Lysergic acid amides and process for their preparation

Also Published As

Publication number Publication date
JPS5218718B2 (nl) 1977-05-24
SE7505974L (sv) 1975-12-01
FI61897B (fi) 1982-06-30
YU135575A (en) 1982-06-30
US4005089A (en) 1977-01-25
FR2272671B1 (nl) 1978-10-06
DK143801C (da) 1982-03-22
DD121639A5 (nl) 1976-08-12
PL98944B1 (pl) 1978-05-31
IL47361A (en) 1979-11-30
DK143801B (da) 1981-10-12
ATA386375A (de) 1978-03-15
BE829518A (fr) 1975-09-15
DK235175A (da) 1975-11-29
HU169073B (nl) 1976-09-28
ES437994A1 (es) 1977-01-16
CS194227B2 (en) 1979-11-30
FR2272671A1 (nl) 1975-12-26
SU625612A3 (ru) 1978-09-25
FI61897C (fi) 1982-10-11
SE419548B (sv) 1981-08-10
AT346501B (de) 1978-11-10
GB1474337A (en) 1977-05-25
BG27374A3 (en) 1979-10-12
NL7506276A (nl) 1975-12-02
CA1051878A (en) 1979-04-03
DE2523743A1 (de) 1975-12-18
JPS516998A (nl) 1976-01-20
IL47361A0 (en) 1975-07-28
AU8142575A (en) 1976-11-25

Similar Documents

Publication Publication Date Title
BR7501663A (nl)
FR2272671B1 (nl)
JPS50102268A (nl)
FR2284204B3 (nl)
AU495028B2 (nl)
JPS50103645A (nl)
BG21451A1 (nl)
BG21143A1 (nl)
BG19878A1 (nl)
BG19714A1 (nl)
BG21745A1 (nl)
BG21808A1 (nl)
BG22113A1 (nl)
BG19694A1 (nl)
BG19972A1 (nl)
BG21508A1 (nl)
BG21503A1 (nl)
BG22561A1 (nl)
BG20685A1 (nl)
BG19564A1 (nl)
BG21271A1 (nl)
BG21161A1 (nl)
BG22331A1 (nl)
AU481934A (nl)
BG21526A1 (nl)

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: RICHTER GEDEON VEGYéSZETI GYAR R.T.